SCHEMBL23959286

SCHEMBL23959286

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(-c2ccn3c(-c4ccccc4)c(-c4ccccc4)nc3n2)cc1C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 11/20 0.45
▸ AKT2 P31751 10/20 0.45
▸ ALDH1A1 P00352 1/20 0.37
▸ DHODH Q02127 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAPK13 O15264 3/20 0.34
▸ MAPK12 P53778 3/20 0.34
▸ MAPK11 Q15759 3/20 0.34
▸ MAPK14 Q16539 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959303 0.91 AKT1 (0.47) AKT1AKT2ALDH1A1MEN1USP2
SCHEMBL23959278 0.90 AKT1 (0.46) AKT1AKT2ALDH1A1DHODHKDM4E
SCHEMBL23959306 0.87 AKT1 (0.50) AKT1AKT2DHODHKDM4EMEN1
SCHEMBL23959297 0.84 AKT2 (0.48) AKT1AKT2MAPTSMN1; SMN2
SCHEMBL23959210 0.81 AKT1 (0.46) AKT1AKT2ALDH1A1DHODHKDM4E
SCHEMBL23959252 0.81 AKT1 (0.43) AKT1AKT2ALDH1A1DHODHKDM4E
SCHEMBL23959118 0.80 AKT1 (0.46) AKT1AKT2ALDH1A1
SCHEMBL23959280 0.77 AKT1 (0.53) AKT1AKT2MEN1USP2MAPK1
SCHEMBL17449606 0.77 ALDH1A1 (0.44) ALDH1A1DHODHKDM4EMEN1KMT2A
SCHEMBL23959285 0.75 AKT1 (0.51) AKT1AKT2KDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ALDH1A1 2829/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ALDH1A1 2829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback